Compare electroCore, Inc. with Similar Stocks
Dashboard
1
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Operating profit has grown by an annual rate 8.45% of over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -18.89
2
Risky -
3
Underperformed the market in the last 1 year
Stock DNA
Pharmaceuticals & Biotechnology
USD 50 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
5.79
1,282.29%
-46.87
Revenue and Profits:
Net Sales:
9 Million
(Quarterly Results - Dec 2025)
Net Profit:
-3 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
41.4%
0%
41.4%
6 Months
25.13%
0%
25.13%
1 Year
-25.42%
0%
-25.42%
2 Years
-10.71%
0%
-10.71%
3 Years
89.97%
0%
89.97%
4 Years
-31.19%
0%
-31.19%
5 Years
-81.32%
0%
-81.32%
electroCore, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
55.90%
EBIT Growth (5y)
8.45%
EBIT to Interest (avg)
-18.89
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.75
Sales to Capital Employed (avg)
4.52
Tax Ratio
0.16%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
17.38%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-46.87
EV to EBIT
-3.32
EV to EBITDA
-3.61
EV to Capital Employed
-6.05
EV to Sales
1.48
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
Bullish
Bollinger Bands
Bullish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
No Trend
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 4 Schemes (3.84%)
Foreign Institutions
Held by 12 Foreign Institutions (2.1%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY
Dec'25
Dec'24
Change(%)
Net Sales
9.20
7.00
31.43%
Operating Profit (PBDIT) excl Other Income
-1.80
-2.50
28.00%
Interest
0.30
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-3.00
-3.20
6.25%
Operating Profit Margin (Excl OI)
-318.20%
-435.90%
11.77%
USD in Million.
Net Sales
YoY Growth in quarter ended Dec 2025 is 31.43% vs 34.62% in Dec 2024
Consolidated Net Profit
YoY Growth in quarter ended Dec 2025 is 6.25% vs 20.00% in Dec 2024
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
32.00
25.20
26.98%
Operating Profit (PBDIT) excl Other Income
-11.50
-10.90
-5.50%
Interest
0.60
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-14.00
-11.90
-17.65%
Operating Profit Margin (Excl OI)
-410.60%
-483.00%
7.24%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 26.98% vs 57.50% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -17.65% vs 36.70% in Dec 2024
About electroCore, Inc. 
electroCore, Inc.
Pharmaceuticals & Biotechnology
ElectroCore, Inc., formerly ElectroCore LLC, is a commercial-stage bioelectronic medicine healthcare company. The Company is engaged in developing non-invasive vagus nerve stimulation (nVNS) therapy for the treatment of multiple conditions in neurology, psychiatry, gastroenterology and respiratory fields. The Company's gammaCore is a simple-to-use hand-held device that provides non-invasive dispensing therapy, which stimulates the cervical branch of the vagus nerve. The gammaCore is a non-drug treatment for adults who suffer from episodic cluster and migraine pain. The Company's target is the treatment of primary headaches (migraine and cluster headache), and the associated chronic co-morbidities of gastric motility, psychiatric, sleep and pain disorders.
Company Coordinates 
Company Details
150 Allen Rd Ste 201 , Basking Ridge NJ : 07920-2977
Registrar Details






